Stepping into the furor over eye-popping price spikes for old generic medicines, a maker of compounded drugs will begin selling $1 doses of Daraprim, whose price recently was jacked up to $750 per pill by Turing Pharmaceuticals.
San Diego-based Imprimis Pharmaceuticals Inc., which mixes approved drug ingredients to fill individual patient prescriptions, said Thursday it will supply capsules containing Daraprim’s active ingredients, pyrimethamine and leucovorin, for $99 for a 100-capsule bottle – or $1 per capsule.
The move to provide cheap alternatives to Daraprim is an attack on Turing CEO Martin Shkreli, who immediately rose the price of the drug by 5,000 per cent after his company acquired it last month.

